NCT05068466View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

January 25, 2022

Study Completion Date

January 25, 2022

Conditions
Healthy Participants
Interventions
DRUG

INCB054707

Administered Orally

DRUG

Placebo

Administered Orally

Trial Locations (1)

813-0017

Souseikai Fukuoka Mirai Hospital, Fukuoka

Sponsors
All Listed Sponsors
lead

Incyte Biosciences Japan GK

INDUSTRY

NCT05068466 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707 | Biotech Hunter | Biotech Hunter